References and Notes
<A NAME="RG37407ST-1">1</A>
Zoidis G.
Fytas C.
Papanastasiou I.
Foscolos GB.
Fytas G.
Padalko E.
Clercq ED.
Naesens L.
Neyts J.
Kolocouris N.
Bioorg. Med. Chem.
2006,
14:
3341
<A NAME="RG37407ST-2">2</A>
Nishiyama S.
Kikuchi Y.
Kurata H.
Yamamura S.
Izawa T.
Nagahata T.
Ikeda R.
Kato K.
Bioorg. Med. Chem. Lett.
1995,
5:
2273
<A NAME="RG37407ST-3">3</A>
Ungureanu I.
Klotz P.
Schoenfelder A.
Mann A.
Chem. Commun.
2001,
958
<A NAME="RG37407ST-4">4</A>
Ungureanu I.
Klotz P.
Schoenfelder A.
Mann A.
Tetrahedron Lett.
2001,
42:
6087
<A NAME="RG37407ST-5">5</A>
Prasad BAB.
Bisai A.
Singh VK.
Org. Lett.
2004,
6:
4829
<A NAME="RG37407ST-6">6</A>
Yadav VK.
Sriramurthy V.
J. Am. Chem. Soc.
2005,
127:
16366
<A NAME="RG37407ST-7">7</A>
Cromwell NH.
Phillips B.
Chem. Rev.
1979,
79:
331
<A NAME="RG37407ST-8">8</A>
Szmuszkovicz J.
Kane MP.
Laurian LG.
Chidester CG.
Scahill TA.
J. Org. Chem.
1981,
46:
3562
<A NAME="RG37407ST-9">9</A>
Causey DH.
Mays RP.
Shamblee DA.
Lo YS.
Synth. Commun.
1988,
18:
205
<A NAME="RG37407ST-10">10</A>
Barluenga J.
Fernández-Mari F.
Viado AL.
Aguilar E.
Olano B.
J. Org. Chem.
1996,
61:
5659
<A NAME="RG37407ST-11">11</A>
Varlamov AV.
Sidorenko NV.
Zubkov FI.
Chernyshev AI.
Chem. Heterocycl. Compd. (Engl. Transl.)
2004,
40:
1097
<A NAME="RG37407ST-12">12</A>
Roos GHP.
Donovan AR.
Tetrahedron: Asymmetry
1999,
10:
991
<A NAME="RG37407ST-13">13</A>
Barluenga J.
Tomás M.
Ballesteros A.
Kong J.-S.
Tetrahedron
1996,
52:
3095
<A NAME="RG37407ST-14">14</A>
Bemis GW.
Murcko MA.
J. Med. Chem.
1996,
39:
2887
<A NAME="RG37407ST-15">15</A>
Schreiber SL.
Science
2000,
287:
1964
<A NAME="RG37407ST-16">16</A>
De Laet A.
Hehenkamp JJ.
Wife RL.
J. Heterocycl. Chem.
2000,
37:
669
<A NAME="RG37407ST-17">17</A>
Janvier P.
Sun X.
Bienayme H.
Zhu J.
J. Am. Chem. Soc.
2002,
124:
2560
<A NAME="RG37407ST-18">18</A>
Sulmon P.
De Kimpe N.
Schamp N.
Tetrahedron
1988,
44:
3653
<A NAME="RG37407ST-19">19</A>
Sulmon P.
De Kimpe N.
Schamp N.
J. Org. Chem.
1989,
54:
2587
<A NAME="RG37407ST-20">20</A>
Sulmon P.
De Kimpe N.
Schamp N.
Tetrahedron
1989,
45:
2937
<A NAME="RG37407ST-21">21</A>
De Kimpe N.
Stevens C.
Synthesis
1993,
89
<A NAME="RG37407ST-22">22</A>
Sulmon P.
De Kimpe N.
Schamp N.
J. Chem. Soc., Chem. Commun.
1985,
715
<A NAME="RG37407ST-23">23</A>
Sulmon P.
De Kimpe N.
Schamp N.
J. Org. Chem.
1988,
53:
4462
<A NAME="RG37407ST-24">24</A>
Aelterman W.
De Kimpe N.
Declercq J.-P.
J. Org. Chem.
1998,
63:
6
<A NAME="RG37407ST-25">25</A>
Yadav LDS.
Awasthi C.
Rai VK.
Rai A.
Tetrahedron Lett.
2007,
48:
8037
<A NAME="RG37407ST-26">26</A>
Chowdhury S.
Mohan RS.
Scott JL.
Tetrahedron
2007,
63:
2363
<A NAME="RG37407ST-27">27</A>
Bao W.
Wang Z.
Green Chem.
2006,
8:
1028
<A NAME="RG37407ST-28">28</A>
Zhao D.
Wu M.
Kou Y.
Min E.
Catal. Today
2002,
74:
157
<A NAME="RG37407ST-29">29</A>
Dupont J.
de Souza RF.
Suarez PAZ.
Chem. Rev.
2002,
102:
3667
<A NAME="RG37407ST-30">30</A>
Qiao K.
Yakoyama C.
Chem. Lett.
2004,
33:
472
<A NAME="RG37407ST-31">31</A>
Sun W.
Xia C.-G.
Wang H.-W.
Tetrahedron Lett.
2003,
44:
2409
<A NAME="RG37407ST-32">32</A>
Kamal A.
Chouhan G.
Tetrahedron Lett.
2005,
46:
1489
<A NAME="RG37407ST-33">33</A>
Earle MJ.
Ktdare SP.
Seddon KR.
Org. Lett.
2004,
6:
707
<A NAME="RG37407ST-34">34</A>
Yadav LDS.
Awasthi C.
Rai VK.
Rai A.
Tetrahedron Lett.
2007,
48:
4899
<A NAME="RG37407ST-35">35</A>
Yadav LDS.
Rai A.
Rai VK.
Awasthi C.
Synlett
2007,
1905
<A NAME="RG37407ST-36">36</A>
Yadav LDS.
Yadav S.
Rai VK.
Green Chem.
2006,
8:
455
<A NAME="RG37407ST-37">37</A>
Yadav LDS.
Yadav S.
Rai VK.
Tetrahedron
2005,
61:
10013
<A NAME="RG37407ST-38">38</A>
Yadav LDS.
Kapoor R.
J. Org. Chem.
2004,
69:
8118
<A NAME="RG37407ST-39">39</A>
General Procedure for the Synthesis of Diethyl N
-Aryl-
N
-(1,3-diaryl-3-oxopropyl)phosphoramidates 3
[25]
To a solution of diethyl N-arylphosphoramidate 2 (5 mmol) in dry benzene (5 mL) was added dropwise a solution of NaH (120 mg, 5 mmol)
in dry benzene (10 mL) with stirring at r.t. After the addition was complete and evolution
of hydrogen gas(effervescence) had ceased, the reaction mixture was stirred at 60
°C for 30 min and then cooled to r.t. Next, a solution of chalcone 1 (5 mmol) in dry benzene (5 mL) was added and the reaction mixture was stirred at
50-60 °C for 3 h. The solvent was evaporated under reduced pressure, the residue washed
with H2O and recrystallized from n-hexane to afford an analytically pure sample of 3.
Physical Data of a Representative Compound
Compound 3a: white crystals yield 87%, mp 186-187 °C. IR (KBr): νmax = 3052, 2990, 1692, 1605, 1582, 1456 cm-1. 1H NMR (400 MHz, CDCl3/TMS): d = 1.23 (t, 6 H, J = 7.5 Hz, 2 Ž Me), 3.06 (dd, 1 H, J = 12.9, 8.5 Hz, 2-Ha), 3.38 (dd, 1 H, J = 12.9, 3.5 Hz, 2-Hb), 4.16 (q, 4 H, J = 7.5 Hz, 2 Ž OCH2), 4.65 (dd, 1 H, J = 8.5, 3.5 Hz, 3-H), 7.08-7.43 (m, 13 Harom), 7.81-7.89 (m, 2 Harom). 13C NMR (100 MHz, CDCl3/TMS): d = 16.3 (Me), 41.7 (CHPh), 50.3 (CH2O), 69.9 (CH2CO), 126.5, 127.5, 128.3, 129.4, 131.4, 132.7, 133.4, 134.2, 135.5 (3 Ž Ph), 193.2
(CO). MS (EI): m/z = 437 [M+]. Anal. Calcd (%) for C25H28NO4P: C, 68.64; H, 6.45; N, 3.20. Found: C, 68.92; H, 6.74; N, 3.07.
<A NAME="RG37407ST-40">40</A>
General Procedure for the Synthesis of Functionalized Azetidines 5
A mixture of adduct 3 (5 mmol) and [bmim]SCN or [bmim]SPh (4, 7.5 mmol) with a few drops of distilled H2O was taken in a 50 mL round-bottomed flask and stirred for 3-4 h at r.t. (for [bmim]SCN)
or at 60-65 °C (for [bmim]SPh). After completion of the reaction as indicated by TLC,
the product was extracted with Et2O (3 × 20 mL), dried over anhyd MgSO4, filtered, and evaporated to dryness. The crude product 5 thus obtained was recrystallized twice from n-hexane to afford an analytically pure sample.
Physical Data of Representative Compounds
Compound 5a: white crystals, yield 81%, mp 98-99 °C. IR (KBr): νmax = 3082, 2965, 2892, 2813, 2132, 1604, 1495, 1451, 753, 706 cm-1. 1H NMR (400 MHz, CDCl3/TMS): δ = 2.75 (dd, 1 H, J = 11.3, 8.7 Hz, 3-Ha), 3.05 (dd, 1 H, J = 11.3, 6.6 Hz, 3-Hb), 4.90 (dd, 1 H, J = 8.7, 6.6 Hz, 4-H), 7.11-7.43 (m, 15 Harom). 13C NMR (100 MHz, CDCl3/TMS): δ = 41.1 (3-C), 55.7, 78.5 (2-C, 4-C), 111.7 (SCN), 123.6, 124.5, 125.3, 126.7,
129.8, 130.7, 131.6, 132.4, 133.5, 134.3, 139.0, 141.7 (3 × Ph). MS (EI): m/z = 342 [M+]. Anal. Calcd (%) for C22H18N2S: C, 77.16; H, 5.30; N, 8.18. Found: C, 76.81; H, 5.53; N, 8.39.
Compound 5g: white crystals, yield 82%, mp 58-59 °C. IR (KBr): νmax = 3073, 2968, 2896, 2818, 1600, 1492, 1456, 758, 696 cm-1. 1H NMR (400 MHz, CDCl3/TMS): δ = 2.79 (dd, 1 H, J = 11.3, 8.7 Hz, 3-Ha), 3.10 (dd, 1 H, J = 11.3, 6.6 Hz, 3-Hb), 4.92 (dd, 1 H, J = 8.7, 6.6 Hz, 4-H), 7.01-7.53 (m, 20 Harom). 13C NMR (100 MHz, CDCl3/TMS): δ = 41.2 (3-C), 55.9, 79.0 (2-C, 4-C), 123.5, 124.6, 125.3, 126.3, 127.2, 128.0,
129.8, 130.6, 131.5, 132.6, 133.4, 134.5, 135.8, 138.2, 139.7, 141.3 (4 × Ph). MS
(EI): m/z = 393 [M+]. Anal. Calcd (%) for C27H23NS: C, 82.40; H, 5.89; N, 3.56. Found: C, 82.76; H, 5.52; N, 3.85.